Netherlands· NL-a94bb73712c8

Nasacort, 55 microgram/ verstuiving neusspray, suspensie

A triamcinolone product containing triamcinolonacetonide, registered in Netherlands by Opella Healthcare France S.A.S.. The same ATC class is registered in 11 of our 19 countries.

ATC R01AD11

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about triamcinolonacetonideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Triamcinolone is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AD11 (triamcinolone), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search triamcinolone products by name

Triamcinolone · ATC R01AD11

11 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TRIAMCINOLONACETONIDE
Manufacturer: Opella Healthcare France S.A.S.
Country: Netherlands (NL)
ATC code: R01AD11
ATC class: Triamcinolone
Defined daily dose: 0.22 mg, N
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
21837

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

38 interactions on record for triamcinolone.

Graded by severity as the source publishes them — 38 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check triamcinolone against other medicines How interaction checks work

Triamcinolone · interactions on record

38 records

38 moderate

Most severe, free to view

MiconazoleA07AC01moderate
LonafarnibA16AX20moderate
VoxelotorB06AX03moderate
ConivaptanC03XA02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Triamcinolone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triamcinolone products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Volon, Volon A
Belgium · Delphi, Kenacort-A
Cyprus · Triacort
Czechia · Triamcinolon Léčiva
Germany · Nasacort, Rhinisan
Denmark · Kenalog, Triamcinolone Acetonide Medipha
Estonia · Kenalog
Spain · Nasacort
Finland · Nasacort, Triamcinolone Medipha
France · Kenacort Retard, Nasacort
United Kingdom (Northern Ireland) · Nasacort
Greece · Jiven, Nasacort
Croatia · Kenalog
Hungary · Ftorocort, Kenalog
Ireland · Nasacort, Nasacort Allergy
Iceland · Kenacort-T, Nasacort
Italy · Kenacort, Nasacort
Lithuania · Ftorocort, Kenalog
Luxembourg · Delphi, Kenacort-A
Latvia · Ftorocort, Kenalog
Malta · Nasacort, Nasacort Allergy
Norway · Kenacort-T, Nasacort
Poland · Polcortolon
Portugal · Nasacort, Telfast Spray Nasal
Sweden · Kenacort-T, Nasacort
Slovenia · Kenalog
Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/784ba1b4-0e85-42fe-94ba-c62af7025c97
GET /v1/drugs/784ba1b4-0e85-42fe-94ba-c62af7025c97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Neusspray, suspensie",
  "route": "Nasaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h21837_smpc.pdf",
  "strength": null,
  "atc_label": "Triamcinolone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21837",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "CARMELLOSE NATRIUM (E 466)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "DINATRIUMEDETAAT 2-WATER",
    "GLUCOSE 0-WATER",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 80 (E 433)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "TRIAMCINOLONACETONIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21837.pdf",
  "authorised_at": "1997/11/05",
  "procedure_number": "PT/H/2256/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "21837",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about triamcinolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console